All filters
Slidesets
(Abstract) Immune reconstitution and skewed responses after ART initiation in HIV I infected Ugandans | K. Nganou Makamdop
Presented at:
INTEREST 2016
Slidesets
(Abstract) HIV-1 group O infection in Cameroon from 2006 to 2013: prevalence, genetic diversity, evolution and public health challenges | A.F. Aghokeng
Presented at:
INTEREST 2016
Slidesets
(Abstract) Outcomes of second-line therapy in HIV positive adults attending for routine care at Yaoundé Central Hospital | A.O. Mafotsing Fopoussi
Presented at:
INTEREST 2016
Slidesets
Progress in Hepatitis B and C in sub-Saharan Africa | Magloire Biwole Sida, MD
Presented at:
INTEREST 2016
Slidesets
HIV Leadership and Financing Strategies for Countries in sub-Saharan Africa | Debrework Zewdie, PhD
Presented at:
INTEREST 2016
Slidesets
Evolving Treatment Paradigms: Relevance in Resource- Limited Settings | Nicholas Paton, MD, FRCP
Presented at:
INTEREST 2016
Slidesets
Acquired Drug Resistance: Causes, Patterns, and Implications for SSA | Coumba Toure Kane, PharmD, PhD
Presented at:
INTEREST 2016
Slidesets
Progress on viral load monitoring, laboratory quality assurance, point of care | John Nkengasong, PhD
Presented at:
INTEREST 2016
Slidesets
Lessons learnt from Ebola Therapeutic Trials and Survivor Cohort Studies | Daouda Sissoko, MD
Presented at:
INTEREST 2016
Slidesets
Lessons learnt About Good Participatory Practices in Prevention and Treatment Trials for HIV and for Emerging Pathogens | Lillian Mutengu
Presented at:
INTEREST 2016
Slidesets
Lessons learnt About the Ethics of Trial Conduct in Emergency Settings | Morenike Ukpong Folayan
Presented at:
INTEREST 2016
Slidesets
Ebola to Lassa Fever: Leassons learnt | Ismail Adeshina Abdus-Salam
Presented at:
INTEREST 2016
Slidesets
Progress in HIV Prevention and Treatment Scale-Up in Sub-Saharan Africa | Claire Mulanga
Presented at:
INTEREST 2016
Slidesets
The Joep Lange Institute / Art and Science in the HIV response | Brandon O’Dell
Presented at:
INTEREST 2016
Slidesets
HIV Testing Strategies: How to Reach 90% Knowledge of Serostatus (including the role of self-testing) | Elizabeth Marum
Presented at:
INTEREST 2016
Slidesets
Lessons learnt from Ebola Vaccine Trials in Emergency Settings | Godwin Enwere, MD, MSc
Presented at:
INTEREST 2016
Slidesets
Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts) | Roselyn Toby
Presented at:
INTEREST 2016
Slidesets
Knowing Your Data - Update on the Epidemiology of HIV in Children and Adolescents | Landry Tsague
Presented at:
INTEREST 2016
Slidesets
Insights and Lessons Learned on Retention, Adherence, and Achieving and Maintaining Viral Suppression: The Third 90 | Tsitsi Apollo
Presented at:
INTEREST 2016